tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Chris Howerton, 125 are a BUY (79.62%), 27 are a HOLD (17.2%), 5 are a SELL (3.18%).
Analyst Chris Howerton, carries an average stock price target met ratio of 57% that have a potential upside of 40.38% achieved within 276 days. Previously, Chris Howerton worked at JEFFERIES.
Chris Howerton’s has documented 311 price targets and ratings displayed on 54 stocks. The coverage was on Healthcare, Consumer Cyclical, Technology sectors.
Most recent stock forecast was given on URGN, UroGen Pharma Ltd at 10-Apr-2026.
Analyst best performing recommendations are on AVD (AMERICAN VANGUARD).
The best stock recommendation documented was for NERV (MINERVA NEUROSCIENCES) at 5/12/2016. The price target of $80 was fulfilled within 14 days with a profit of $35.44 (79.53%) receiving and performance score of 56.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Apr-2025
$36
$10.13 (39.16%)
$26
Hold Since 20-Jun-2022
$25
$-0.87 (-3.36%)
$24
Buy Since 23-Jun-2025
$36
$10.13 (39.16%)
$30
Buy Since 30-Jun-2026
$30
$4.13 (15.96%)
$29
Buy Since 21-Oct-2025
$35
$9.13 (35.29%)
$32
Which stock is Chris Howerton is most bullish on?
What Year was the first public recommendation made by Chris Howerton?
